"Het Beatrixziekenhuis is een regionaal ziekenhuis met een breed aanbod van specialismen en moderne medische voorzieningen. Samen met onze patiënten realiseren wij de beste zorg; mensgericht, veilig, dichtbij, en op het juiste moment. Het Beatrixziekenhuis maakt deel uit van Rivas Zorggroep, een ketenorganisatie met bijna alle vormen van zorg. Vervolgzorg na een ziekenhuisopname kan daardoor snel en goed geregeld worden. Ook met onze partners verbeteren wij voortdurend de zorg. De lijnen tussen huisartsen in de regio en specialisten zijn kort. Daarnaast werken we nauw samen met andere, ook academische, ziekenhuizen."

During the past decade, Beatrix Hospital conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 3 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Beatrix Hospital" #1 sponsor was "Pfizer" with 3 trials, followed by "Borstkanker Onderzoek Groep" with 2 trials sponsored, "Stichting Hemato-Oncologie voor Volwassenen Nederland" with 2 trials sponsored, "Amsterdam UMC, location VUmc" with 1 trials sponsored and "Bayer" with 1 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Beatrix Hospital" #1 collaborator was "Australasian Leukaemia and Lymphoma Group" with 1 trials as a collaborator, "BOOG Study Center" with 1 trials as a collaborator, "Central European Myeloma Study Group" with 1 trials as a collaborator, "DSMM (Deutsche Studiengruppe Multiples Myelom)" with 1 trials as a collaborator and "Disphar International B.V." with 1 trials as a collaborator. Other collaborators include 17 different institutions and companies that were collaborators in the rest 27 trials.

According to Clinical.Site data, the most researched conditions in "Beatrix Hospital" are "Cardiovascular Disease" (2 trials), "Acute Coronary Event" (1 trials), "Adjuvant Therapy" (1 trials), "Atrial Fibrillation" (1 trials) and "Breast Cancer" (1 trials). Many other conditions were trialed in "Beatrix Hospital" in a lesser frequency.

Most popular intervention types in "Beatrix Hospital" are "Drug" (12 trials), "Other" (3 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "bococizumab (PF-04950615)" (2 trials), "1 or 2 cycle(s) HDM (High Dose Melphalan)" (1 trials), "2 cycles of Bortezomib, Lenalidomide, Dexamethasone (VRD)" (1 trials) and "Acetylsalicylic acid" (1 trials). Other intervention names were less common.

The vast majority of trials in "Beatrix Hospital" are 13 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Beatrix Hospital". undefined are not yet recruiting, 2 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Beatrix Hospital, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Beatrix Hospital, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".